Indocin and Melatonin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Indocin (indomethacin) and Melatonin (melatonin). Common drug interactions include hyperhidrosis among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Indocin and Melatonin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Indocin?

Indocin has active ingredients of indomethacin. It is often used in gout. eHealthMe is studying from 4,559 Indocin users. Check the latest studies of Indocin.

What is Melatonin?

Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.



On Jul, 14, 2026

16 people who take Indocin and Melatonin together, and have interactions are studied.

Indocin and Melatonin drug interactions.

What are the common drug interactions of Indocin and Melatonin, by gender? *:

female:

  1. Hyperhidrosis (abnormally increased sweating)
  2. Hypersensitivity
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  5. Psoriasis (immune-mediated disease that affects the skin)
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Thyroid cancer
  9. Vaginal haemorrhage (vaginal bleeding)
  10. Renal failure acute (rapid kidney dysfunction)

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  3. Arthralgia (joint pain)
  4. Ascites (accumulation of fluid in the abdominal cavity)
  5. Asthenia (weakness)
  6. Atelectasis (partial or complete collapse of the lung)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Biliary tract disorder
  9. Bradycardia (abnormally slow heart action)
  10. Cachexia (loss of weight)

What are the common drug interactions of Indocin and Melatonin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephropathy (damage to or disease of a kidney)

40-49:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)

50-59:

  1. Pharyngitis (inflammation of the pharynx, causing a sore throat)
  2. Renal failure acute (rapid kidney dysfunction)
  3. Thyroid cancer
  4. Abscess oral (abscess in the mouth)
  5. Feeling cold
  6. Flushing (the warm, red condition of human skin)
  7. Heart rate increased
  8. Hypersensitivity
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  3. Ascites (accumulation of fluid in the abdominal cavity)
  4. Asthenia (weakness)
  5. Atelectasis (partial or complete collapse of the lung)
  6. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  7. Biliary tract disorder
  8. Bradycardia (abnormally slow heart action)
  9. Cachexia (loss of weight)
  10. Cardiomegaly (increased size of heart than normal)

What are the existing conditions these people have? *

  1. Joint Pain: 7 people, 43.75%
  2. Nausea (feeling of having an urge to vomit): 6 people, 37.50%
  3. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 4 people, 25.00%
  4. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 25.00%
  5. Constipation: 4 people, 25.00%
  6. Febrile Neutropenia (fever with reduced white blood cells): 4 people, 25.00%
  7. Fever: 4 people, 25.00%
  8. Hypokalemia (low potassium): 4 people, 25.00%
  9. Abdominal Pain: 4 people, 25.00%
  10. Pulmonary Oedema (fluid accumulation in the lungs): 4 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Indocin and Melatonin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Indocin and Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Indocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Melatonin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Indocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Melatonin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on indomethacin and melatonin (the active ingredients of Indocin and Melatonin, respectively), and Indocin and Melatonin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: